CCND1 and neoplasm: In contrast, our findings show that copanlisib suppresses tumor growth in HCC cells mainly by triggering a G1 cell cycle arrest by inhibiting the cyclin D1/CDK4/CDK6 axis (Fig. 8b), without causing apoptosis (Fig. 3).